Politics · United States · 2 hrs ago
US panel warns China is gaining ground in biopharmaceuticals
A US congressional advisory body warned that China’s biopharmaceutical sector is rising quickly in its annual report, published on Thursday.
The report said China was gaining a competitive advantage in the field.
Western companies are paying large upfront fees to license Chinese drugs, which the panel linked to China’s growing ability to develop new medicines.
At a congressional hearing, commission member Leland Miller said China could become an innovation hub that might replace the United States.
The warning is adding to Washington’s push to curb cross-border ties in the sector.
Chinese biotech companies appear largely unfazed, while some experts have warned that plans to build up local industries could backfire.